| Epigenetic disregulation in oral cancer M Mascolo, M Siano, G Ilardi, D Russo, F Merolla, G De Rosa, S Staibano International journal of molecular sciences 13 (2), 2331-2353, 2012 | 164 | 2012 |
| Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human … E Martinelli, T Troiani, E D'Aiuto, F Morgillo, D Vitagliano, A Capasso, ... International journal of cancer 133 (9), 2089-2101, 2013 | 108 | 2013 |
| Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness A Celetti, D Testa, S Staibano, F Merolla, V Guarino, MD Castellone, ... Clinical cancer research 11 (22), 8019-8027, 2005 | 104 | 2005 |
| Reduced E-cadherin expression contributes to the loss of p27 kip1 -mediated mechanism of contact inhibition in thyroid anaplastic carcinomas ML Motti, D Califano, G Baldassarre, A Celetti, F Merolla, F Forzati, ... Carcinogenesis 26 (6), 1021-1034, 2005 | 88 | 2005 |
| H4 (D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization A Celetti, A Cerrato, F Merolla, D Vitagliano, G Vecchio, M Grieco Oncogene 23 (1), 109-121, 2004 | 81 | 2004 |
| Primary and acquired resistance of colorectal cancer to anti-EGFR monoclonal antibody can be overcome by combined treatment of regorafenib with cetuximab S Napolitano, G Martini, B Rinaldi, E Martinelli, M Donniacuo, L Berrino, ... Clinical Cancer Research 21 (13), 2975-2983, 2015 | 76 | 2015 |
| USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs U Malapelle, F Morra, G Ilardi, R Visconti, F Merolla, A Cerrato, ... Lung Cancer 107, 41-49, 2017 | 65 | 2017 |
| NCOA4 transcriptional coactivator inhibits activation of DNA replication origins R Bellelli, MD Castellone, T Guida, R Limongello, NA Dathan, F Merolla, ... Molecular cell 55 (1), 123-137, 2014 | 61 | 2014 |
| The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells F Morra, F Merolla, V Napolitano, G Ilardi, C Miro, S Paladino, S Staibano, ... Oncotarget 8 (19), 31815, 2017 | 60 | 2017 |
| Involvement of H4 (D10S170) protein in ATM-dependent response to DNA damage F Merolla, F Pentimalli, R Pacelli, G Vecchio, A Fusco, M Grieco, A Celetti Oncogene 26 (42), 6167-6175, 2007 | 57 | 2007 |
| New therapeutic perspectives in CCDC 6 deficient lung cancer cells F Morra, C Luise, R Visconti, S Staibano, F Merolla, G Ilardi, G Guggino, ... International journal of cancer 136 (9), 2146-2157, 2015 | 55 | 2015 |
| Overexpression of chromatin assembly factor‐1 p60, poly (ADP‐ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer M Mascolo, G Ilardi, MF Romano, A Celetti, M Siano, S Romano, C Luise, ... Histopathology 61 (6), 1089-1105, 2012 | 55 | 2012 |
| FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC F Morra, C Luise, F Merolla, I Poser, R Visconti, G Ilardi, S Paladino, ... Oncotarget 6 (14), 12697, 2015 | 52 | 2015 |
| OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome S Staibano, F Merolla, D Testa, R Iovine, M Mascolo, V Guarino, ... British journal of cancer 97 (11), 1545-1551, 2007 | 49 | 2007 |
| CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1 V Leone, G Mansueto, GM Pierantoni, M Tornincasa, F Merolla, A Cerrato, ... Oncogene 29 (30), 4341-4351, 2010 | 48 | 2010 |
| Epigenetics of oral and oropharyngeal cancers (Review) Corrigendum in/10.3892/br. 2020.1290 D Russo, F Merolla, S Varricchio, G Salzano, G Zarrilli, M Mascolo, ... Biomedical reports 9 (4), 275-283, 2018 | 47 | 2018 |
| Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage F Merolla, C Luise, MT Muller, R Pacelli, A Fusco, A Celetti PloS one 7 (5), e36177, 2012 | 45 | 2012 |
| FKBP51 immunohistochemical expression: a new prognostic biomarker for OSCC? D Russo, F Merolla, M Mascolo, G Ilardi, S Romano, S Varricchio, ... International journal of molecular sciences 18 (2), 443, 2017 | 42 | 2017 |
| Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers G Ilardi, N Zambrano, F Merolla, M Siano, S Varricchio, M Vecchione, ... Current medicinal chemistry 21 (14), 1569-1582, 2014 | 41 | 2014 |
| RETRACTED ARTICLE: Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors S Staibano, G Ilardi, V Leone, C Luise, F Merolla, F Esposito, F Morra, ... BMC cancer 13, 1-12, 2013 | 37 | 2013 |
